Status: current, Defined. Date: 31-Mar 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4797121000168111 | davesomeran + elasomeran (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4797131000168114 | elasomeran + davesomeran | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| elasomeran + davesomeran | Is a | elasomeran | true | Inferred relationship | Some | ||
| elasomeran + davesomeran | has intended active ingredient | davesomeran | true | Inferred relationship | Some | 1951186082 | |
| elasomeran + davesomeran | has intended active ingredient | elasomeran | true | Inferred relationship | Some | 153511126 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, 2.5 mL vial | Is a | True | elasomeran + davesomeran | Inferred relationship | Some | |
| elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, syringe | Is a | True | elasomeran + davesomeran | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR